Tagged: myomo

Via Folio Helps Alternative Investing Platforms Manage Funds & Investors

Via Folio is out with a statement on their services that help non-traditional issuers manage both assets and investors. Via Folio provides a vital bridge between issuers in newer securities like Regulation A+, as created by the JOBS Act. Reg A+ has seen growing utilization… Read More

Reg A+ Issuer Adomani Trades Higher Following Mini-IPO Crowdfunding Offer

Last week there were two companies that raised money crowdfunding under Reg A+ and soon followed by trading on a public exchange. Myomo (NYSE:MYO), raised capital on Banq, and then listed on NYSE MKT. The shares have since traded to a high of about $23 /… Read More

Reg A+ Issuer MyomoTrades Up Following Listing on NYSE MKT

It has been one week since Myomo (NYSE:MYO) became the first Reg A+ issuer to successfully crowdfund and then list on NYSE MKT.  But since listing on the public exchange, Myomo has moved in the right direction.  The shares have rocketed from an issue price of… Read More

Is Reg A+ Crowdfunding Quickly Coming of Age?

Next week two smaller companies intend on listing their shares on a public exchange. What is interesting about this fact is that each of these companies used Regulation A or Reg A+ to facilitate this “mini-IPO” type offer. Created by Title IV of the JOBS… Read More

Myomo Will Become First Reg A+ Issuer to Trade on NYSE MKT

Myomo, a medical robotics company that has developed powered brace to support a weak arm, will become the first Regulation A (Reg A+) issuer to immediately go from crowdfunding to actively trading on an exchange. Myomo will begin trading on the New York Stock Exchange… Read More

Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?

We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Under the exemption, Myomo was seeking $15 million using Banq, a crowdfunding platform… Read More

Myomo Wants to be the First Company to Issue Shares Under Reg A+ & then Trade on the NYSE

Reg A+, a securities exemption that was improved under the JOBS Act, has been touted as the solution to the dearth of IPOs in the US. But issuers are still working to figure out the best avenue to raise capital and then publicly trade shares…. Read More

Mark Elenowitz of TriPoint Global: Reg A+ is the Future of IPOs

There has been a lot of buzz within the investment community regarding the updated exemption created under Title IV of the JOBS Act.  Regulation A+, or just Reg A+, was crafted by the SEC and Congress to allow issuers to raise up to $50 million… Read More

Myomo Files for Reg A+ Offer. Expects to List on NYSE Following Funding Round

Myomo, a medical robotics company whose products enable users to overcome upper extremity paralysis, has filed a Form 1-A with the SEC indicating its intent to raise money under Reg A+, a crowdfunding exemption that allows issuers to seek up to $50 million in capital…. Read More